{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:09:35Z","timestamp":1766167775563,"version":"3.48.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Synskadades V\u00e4nner Skaraborg"},{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Exfoliative glaucoma (XFG) is characterized by elevated intraocular pressure (IOP) caused by fibrous deposits obstructing aqueous humor drainage, traditionally emphasizing mechanical factors. In this study, we aim to investigate the relationships between clinical parameters and autoimmune activity in exfoliative glaucoma (XFG) patients, and identify patterns of autoantibody reactivity among patient subgroups with differing levels of overall autoimmune activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed serum autoantibody profiles against 92 antigens in 116 XFG patients using an xMAP suspension bead array. Spearman correlation analysis and PERMANOVA were applied to evaluate relationships between autoantibody reactivity and clinical parameters in glaucoma management. Hierarchical clustering was used to identify clusters of patients based on overall autoantibody reactivity levels, and network analysis using shortest path mapping was utilized to explore potential connections among the proteins associated with the antigens used in this study and other proteins not targeted in this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Significant positive correlations were found between the clinical parameter SE and autoantibodies targeting the proteins LOXL3, CYP39A1, and HYOU1. Clustering analysis revealed distinct subgroups of patients with differing overall autoantibody reactivity levels, notably showing significant negative correlations between broad autoantibody profiles and CCT exclusively within the subgroup characterized by higher autoimmune activity. Network analysis identified CTNNB1 as a prominent multi-path intermediary connecting disparate proteins, highlighting potential common regulatory pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identifies novel correlations between clinical parameters and autoimmune activity in XFG, suggesting refractive changes and corneal structural characteristics may be influenced by specific immune mechanisms. These findings underscore the value of integrating immunological profiling with clinical glaucoma assessments, potentially enhancing patient stratification and identifying possible therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10792-025-03783-0","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T07:00:03Z","timestamp":1759474803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation of autoantibody profiles with clinical parameters in exfoliative glaucoma patients"],"prefix":"10.1007","volume":"45","author":[{"given":"Ryan","family":"Potter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Tilevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"221","key":"3783_CR1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/bs.pbr.2015.06.007","volume":"1","author":"S Miglior","year":"2015","unstructured":"Miglior S, Bertuzzi F (2015) Exfoliative glaucoma: new evidence in the pathogenesis and treatment. Prog Brain Res 1(221):233\u2013241","journal-title":"Prog Brain Res"},{"issue":"7","key":"3783_CR2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archopht.126.7.914","volume":"126","author":"TV Johnson","year":"2008","unstructured":"Johnson TV, Fan S, Camras CB, Toris CB (2008) Aqueous humor dynamics in exfoliation syndrome. Arch Ophthalmol 126(7):914\u2013920","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"3783_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/ICU.0b013e32834ff23e","volume":"23","author":"WD Stamer","year":"2012","unstructured":"Stamer WD, Acott TS (2012) Current understanding of conventional outflow dysfunction in glaucoma. Curr Opin Ophthalmol 23(2):135\u2013143","journal-title":"Curr Opin Ophthalmol"},{"issue":"10","key":"3783_CR4","doi-asserted-by":"crossref","first-page":"e1180","DOI":"10.1002\/cti2.1180","volume":"9","author":"D Wakefield","year":"2020","unstructured":"Wakefield D, Wildner G (2020) Is glaucoma an autoimmune disease? Clin Trans Immunol 9(10):e1180","journal-title":"Clin Trans Immunol"},{"issue":"7","key":"3783_CR5","first-page":"1134","volume":"63","author":"PA Williams","year":"2022","unstructured":"Williams PA, Tribble JR, J\u00f6e M, Brancale A, Varricchio C, Coleman M et al (2022) Targeting NMNAT2 for neuroprotection in glaucoma. Invest Ophthalmol Vis Sci 63(7):1134\u20131134","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3783_CR6","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1038\/s41467-024-50354-5","volume":"15","author":"JR Tribble","year":"2024","unstructured":"Tribble JR, J\u00f6e M, Varricchio C, Otmani A, Canovai A, Habchi B et al (2024) NMNAT2 is a druggable target to drive neuronal NAD production. Nat Commun 15(1):6256","journal-title":"Nat Commun"},{"issue":"1","key":"3783_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12886-024-03314-y","volume":"24","author":"R Potter","year":"2024","unstructured":"Potter R, Ayala M, Tilevik A (2024) Identification of biomarker candidates for exfoliative glaucoma from autoimmunity profiling. BMC Ophthalmol 24(1):44. https:\/\/doi.org\/10.1186\/s12886-024-03314-y","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"3783_CR8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00055735-200404000-00003","volume":"15","author":"G Tezel","year":"2004","unstructured":"Tezel G, Wax MB (2004) The immune system and glaucoma. Curr Opin Ophthalmol 15(2):80\u201384","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"3783_CR9","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1167\/iovs.09-4898","volume":"51","author":"EW Dervan","year":"2010","unstructured":"Dervan EW, Chen H, Ho SL, Brummel N, Schmid J, Toomey D, Murphy D (2010) Protein macroarray profiling of serum autoantibodies in pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 51(6):2968\u20132975","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"3783_CR10","first-page":"6111","volume":"51","author":"K Lorenz","year":"2010","unstructured":"Lorenz K, Schlich M, Boehm N, Kramann C, Pfeiffer N, Grus F (2010) Detection of autoantibody patterns in sera of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma and cataract (Control Group). Invest Ophthalmol Vis Sci 51(13):6111\u20136111","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"15","key":"3783_CR11","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1523\/JNEUROSCI.4401-10.2011","volume":"31","author":"R Dodel","year":"2011","unstructured":"Dodel R, Balakrishnan K, Keyvani K, Deuster O, Neff F, Andrei-Selmer LC, Bacher M (2011) Naturally occurring autoantibodies against \u03b2-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer\u2019s disease. J Neurosci 31(15):5847\u20135854","journal-title":"J Neurosci"},{"key":"3783_CR12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fimmu.2019.00672","volume":"10","author":"JM Thurman","year":"2019","unstructured":"Thurman JM, Yapa R (2019) Complement therapeutics in autoimmune disease. Front Immunol 10:672","journal-title":"Front Immunol"},{"issue":"1","key":"3783_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10875-014-0025-4","volume":"34","author":"C Gr\u00f6nwall","year":"2014","unstructured":"Gr\u00f6nwall C, Silverman GJ (2014) Natural IgM: Beneficial autoantibodies for the control of inflammatory and autoimmune disease. J Clin Immunol 34(1):12\u201321","journal-title":"J Clin Immunol"},{"issue":"12","key":"3783_CR14","first-page":"2277","volume":"39","author":"G Tezel","year":"1998","unstructured":"Tezel G, Seigel GM, Wax MB (1998) Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci 39(12):2277\u20132287","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1327137","key":"3783_CR15","first-page":"13","volume":"10","author":"FH Grus","year":"2004","unstructured":"Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N (2004) Complex autoantibody repertoires in patients with glaucoma. Mol Vis 10(1327137):13\u201317","journal-title":"Mol Vis"},{"issue":"4","key":"3783_CR16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ogla.2020.04.009","volume":"3","author":"J Phu","year":"2020","unstructured":"Phu J, Khuu SK, Agar A, Domadious I, Ng A, Kalloniatis M (2020) Visualizing the consistency of clinical characteristics that distinguish healthy persons, glaucoma suspect patients, and manifest glaucoma patients. Ophthalmol Glaucoma 3(4):274\u2013287","journal-title":"Ophthalmol Glaucoma"},{"issue":"1","key":"3783_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bjophthalmol-2020-317112","volume":"105","author":"GL Spaeth","year":"2021","unstructured":"Spaeth GL (2021) European glaucoma society terminology and guidelines for glaucoma. Br J Ophthalmol 105(1):1\u2013169","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3783_CR18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ogla.2018.11.004","volume":"2","author":"AT Nguyen","year":"2019","unstructured":"Nguyen AT, Greenfield DS, Bhakta AS, Lee J, Feuer WJ (2019) Detecting glaucoma progression using guided progression analysis with oct and visual field assessment in eyes classified by international classification of disease severity codes. Ophthalmol Glaucoma 2(1):36\u201346","journal-title":"Ophthalmol Glaucoma"},{"issue":"2","key":"3783_CR19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1167\/iovs.08-1789","volume":"50","author":"M Wall","year":"2009","unstructured":"Wall M, Woodward KR, Doyle CK, Artes PH (2009) Repeatability of automated perimetry: a comparison between standard automated perimetry with stimulus size III and V, matrix, and motion perimetry. Invest Ophthalmol Vis Sci 50(2):974\u2013979","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3783_CR20","doi-asserted-by":"crossref","first-page":"18113","DOI":"10.1038\/s41598-019-54653-6","volume":"9","author":"SI Berchuck","year":"2019","unstructured":"Berchuck SI, Mukherjee S, Medeiros FA (2019) Estimating rates of progression and predicting future visual fields in glaucoma using a deep variational autoencoder. Sci Rep 9(1):18113","journal-title":"Sci Rep"},{"issue":"7","key":"3783_CR21","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/bjophthalmol-2017-310635","volume":"102","author":"A Salonikiou","year":"2018","unstructured":"Salonikiou A, Founti P, Kilintzis V, Antoniadis A, Anastasopoulos E, Pappas T, Topouzis F (2018) Tolerable rates of visual field progression in a population-based sample of patients with glaucoma. Br J Ophthalmol 102(7):916\u2013921","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"3783_CR22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/IJG.0000000000000710","volume":"26","author":"K Liebmann","year":"2017","unstructured":"Liebmann K, De Moraes CG, Liebmann JM (2017) Measuring rates of visual field progression in linear versus nonlinear scales: implications for understanding the relationship between baseline damage and target rates of glaucoma progression. J Glaucoma 26(8):721\u2013725","journal-title":"J Glaucoma"},{"issue":"1","key":"3783_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12864-016-2888-7","volume":"17","author":"TK Rausch","year":"2016","unstructured":"Rausch TK, Schillert A, Ziegler A, L\u00fcking A, Zucht HD, Schulz-Knappe P (2016) Comparison of pre-processing methods for multiplex bead-based immunoassays. BMC Genomics 17(1):601. https:\/\/doi.org\/10.1186\/s12864-016-2888-7","journal-title":"BMC Genomics"},{"issue":"6","key":"3783_CR24","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2353\/ajpath.2008.080535","volume":"173","author":"U Schl\u00f6tzer-Schrehardt","year":"2008","unstructured":"Schl\u00f6tzer-Schrehardt U, Pasutto F, Sommer P, Hornstra I, Kruse FE, Naumann GO, Zenkel M (2008) Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome\/glaucoma and normal patients. Am J Pathol 173(6):1724\u20131735","journal-title":"Am J Pathol"},{"issue":"8","key":"3783_CR25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1089\/jop.2019.0118","volume":"36","author":"N Rahman","year":"2020","unstructured":"Rahman N, O\u2019Neill E, Irnaten M, Wallace D, O\u2019Brien C (2020) Corneal stiffness and collagen cross-linking proteins in glaucoma: potential for novel therapeutic strategy. J Ocul Pharmacol Ther 36(8):582\u2013594. https:\/\/doi.org\/10.1089\/jop.2019.0118","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"3783_CR26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ophtha.2021.11.001","volume":"129","author":"K Bell","year":"2022","unstructured":"Bell K, Ozaki M, Mori K, Mizoguchi T, Nakano S, Porporato N, Aung T (2022) Association of the CYP39A1 G204E genetic variant with increased risk of glaucoma and blindness in patients with exfoliation syndrome. Ophthalmology 129(4):406\u2013413","journal-title":"Ophthalmology"},{"issue":"1","key":"3783_CR27","doi-asserted-by":"crossref","first-page":"20541","DOI":"10.1038\/s41598-023-47942-8","volume":"13","author":"NY Nsiah","year":"2023","unstructured":"Nsiah NY, Morgan AB, Donkor N, Inman DM (2023) Long-term HIF-1\u03b1 stabilization reduces respiration, promotes mitophagy, and results in retinal cell death. Sci Rep 13(1):20541","journal-title":"Sci Rep"},{"issue":"3","key":"3783_CR28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jphs.2014.12.019","volume":"127","author":"C Wilding","year":"2015","unstructured":"Wilding C, Bell K, Funke S, Beck S, Pfeiffer N, Grus FH (2015) GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57. J Pharmacol Sci 127(3):298\u2013304","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"3783_CR29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/jnc.13765","volume":"139","author":"K Bell","year":"2016","unstructured":"Bell K, Wilding C, Funke S, Perumal N, Beck S, Wolters D, Grus FH (2016) Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture. J Neurochem 139(2):256\u2013269","journal-title":"J Neurochem"},{"issue":"2","key":"3783_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00296-023-05446-8","volume":"44","author":"LI Sakkas","year":"2024","unstructured":"Sakkas LI, Chikanza IC (2024) Sex bias in immune response: it is time to include the sex variable in studies of autoimmune rheumatic diseases. Rheumatol Int 44(2):203\u2013209. https:\/\/doi.org\/10.1007\/s00296-023-05446-8","journal-title":"Rheumatol Int"},{"issue":"1","key":"3783_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12974-021-02229-5","volume":"18","author":"L Biscetti","year":"2021","unstructured":"Biscetti L, De Vanna G, Cresta E, Corbelli I, Gaetani L, Cupini L, Sarchielli P (2021) Headache and immunological\/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms. J Neuroinflammation 18(1):259. https:\/\/doi.org\/10.1186\/s12974-021-02229-5","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3783_CR32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12974-021-02229-5","volume":"18","author":"L Biscetti","year":"2021","unstructured":"Biscetti L, De Vanna G, Cresta E, Corbelli I, Gaetani L, Cupini L, Sarchielli P (2021) Headache and immunological\/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms. J Neuroinflammation 18(1):259","journal-title":"J Neuroinflammation"},{"issue":"5","key":"3783_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/JLB.3MR0220-243R","volume":"107","author":"M Prasad","year":"2020","unstructured":"Prasad M, Chen EW, Toh SA, Gascoigne NR (2020) Autoimmune responses and inflammation in type 2 diabetes. J Leukoc Biol 107(5):739\u2013748. https:\/\/doi.org\/10.1002\/JLB.3MR0220-243R","journal-title":"J Leukoc Biol"},{"issue":"19","key":"3783_CR34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cophys.2020.09.016","volume":"1","author":"DM Patrick","year":"2021","unstructured":"Patrick DM, Van Beusecum JP, Kirabo A (2021) The role of inflammation in hypertension: novel concepts. Curr Opin Physiol 1(19):92\u201398","journal-title":"Curr Opin Physiol"},{"issue":"1","key":"3783_CR35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archopht.122.1.17","volume":"122","author":"LW Herndon","year":"2004","unstructured":"Herndon LW, Weizer JS, Stinnett SS (2004) Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 122(1):17\u201321","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"3783_CR36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41433-018-0033-3","volume":"32","author":"GW Belovay","year":"2018","unstructured":"Belovay GW, Goldberg I (2018) The thick and thin of the central corneal thickness in glaucoma. Eye 32(5):915\u2013923","journal-title":"Eye"},{"issue":"2","key":"3783_CR37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00061198-200604000-00003","volume":"15","author":"C Kniestedt","year":"2006","unstructured":"Kniestedt C, Lin S, Choe J, Nee M, Bostrom A, St\u00fcrmer J, Stamper RL (2006) Correlation between intraocular pressure, central corneal thickness, stage of glaucoma, and demographic patient data: prospective analysis of biophysical parameters in tertiary glaucoma practice populations. J Glaucoma 15(2):91\u201397","journal-title":"J Glaucoma"},{"issue":"11","key":"3783_CR38","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/S0161-6420(99)90498-0","volume":"106","author":"S Shah","year":"1999","unstructured":"Shah S, Chatterjee A, Mathai M, Kelly SP, Kwartz J, Henson D et al (1999) Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology 106(11):2154\u20132160","journal-title":"Ophthalmology"},{"issue":"4","key":"3783_CR39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/1073858413516799","volume":"20","author":"M Schwartz","year":"2014","unstructured":"Schwartz M, Raposo C (2014) Protective autoimmunity: A unifying model for the immune network involved in CNS repair. Neuroscientist 20(4):343\u2013358","journal-title":"Neuroscientist"},{"issue":"4","key":"3783_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/intimm\/dxs155","volume":"25","author":"Y Jiang","year":"2013","unstructured":"Jiang Y, Arase N, Kohyama M, Hirayasu K, Suenaga T, Jin H, Arase H (2013) Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules. Int Immunol 25(4):235\u2013246. https:\/\/doi.org\/10.1093\/intimm\/dxs155","journal-title":"Int Immunol"},{"issue":"10","key":"3783_CR41","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1073\/pnas.1401105111","volume":"111","author":"H Jin","year":"2014","unstructured":"Jin H, Arase N, Hirayasu K, Kohyama M, Suenaga T, Saito F, Arase H (2014) Autoantibodies to IgG\/HLA class II complexes are associated with rheumatoid arthritis susceptibility. Proc Nat Acad Sci 111(10):3787\u20133792. https:\/\/doi.org\/10.1073\/pnas.1401105111","journal-title":"Proc Nat Acad Sci"},{"issue":"129","key":"3783_CR42","first-page":"1","volume":"1","author":"H Arase","year":"2016","unstructured":"Arase H (2016) Rheumatoid rescue of misfolded cellular proteins by mhc class ii molecules: a new hypothesis for autoimmune diseases. Adv Immunol 1(129):1\u201323","journal-title":"Adv Immunol"},{"issue":"2","key":"3783_CR43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0378(98)00009-6","volume":"38","author":"G Ljunggren","year":"1998","unstructured":"Ljunggren G, Anderson DJ (1998) Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells. J Reprod Immunol 38(2):123\u2013138","journal-title":"J Reprod Immunol"},{"issue":"4","key":"3783_CR44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/intimm\/dxs155","volume":"25","author":"Y Jiang","year":"2013","unstructured":"Jiang Y, Arase N, Kohyama M, Hirayasu K, Suenaga T, Jin H, Arase H (2013) Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules. Int Immunol 25(4):235\u2013246","journal-title":"Int Immunol"},{"issue":"6968","key":"3783_CR45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","volume":"426","author":"AL Goldberg","year":"2003","unstructured":"Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426(6968):895\u2013899","journal-title":"Nature"},{"issue":"6779","key":"3783_CR46","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35008096","volume":"404","author":"U Schubert","year":"2000","unstructured":"Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404(6779):770\u2013774","journal-title":"Nature"},{"issue":"2","key":"3783_CR47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physiolgenomics.90261.2008","volume":"38","author":"N Comes","year":"2009","unstructured":"Comes N, Borr\u00e1s T (2009) Individual molecular response to elevated intraocular pressure in perfused postmortem human eyes. Physiol Genomics 38(2):205\u2013225","journal-title":"Physiol Genomics"},{"issue":"1","key":"3783_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12886-025-03939-7","volume":"25","author":"D Choi","year":"2025","unstructured":"Choi D, Na AY, Jeoung SW, Choi YH, Park N, Park HS, Ryu HY (2025) Histone H3 lysine 9 tri-methylation is associated with pterygium. BMC Ophthalmol 25(1):106. https:\/\/doi.org\/10.1186\/s12886-025-03939-7","journal-title":"BMC Ophthalmol"},{"issue":"11","key":"3783_CR49","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1167\/iovs.13-12652","volume":"55","author":"G Villarreal","year":"2014","unstructured":"Villarreal G, Chatterjee A, Oh SS, Oh DJ, Kang MH, Rhee DJ (2014) Canonical wnt signaling regulates extracellular matrix expression in the trabecular meshwork. Invest Ophthalmol Vis Sci 55(11):7433\u20137440","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"3783_CR50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.61.6.30","volume":"61","author":"K Dhamodaran","year":"2020","unstructured":"Dhamodaran K, Baidouri H, Sandoval L, Raghunathan V (2020) Wnt activation after inhibition restores trabecular meshwork cells toward a normal phenotype. Invest Ophthalmol Vis Sci 61(6):30\u201330. https:\/\/doi.org\/10.1167\/iovs.61.6.30","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3783_CR51","first-page":"3677","volume":"56","author":"Y Yuan","year":"2015","unstructured":"Yuan Y, Zhang L, Dong F, Zhang Y, Call M, Liu CY, Kao W (2015) Activation of noncanonical wnt signaling elicits glaucoma in mice. Invest Ophthalmol Vis Sci 56(7):3677\u20133677","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3783_CR52","first-page":"1056","volume":"118","author":"WH Wang","year":"2008","unstructured":"Wang WH, McNatt LG, Pang IH, Millar JC, Hellberg PE, Hellberg MH, Clark AF (2008) Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure. J Clin Investig 118(3):1056\u20131064","journal-title":"J Clin Investig"},{"issue":"1","key":"3783_CR53","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1038\/ncomms5393","volume":"5","author":"R Sheng","year":"2014","unstructured":"Sheng R, Kim H, Lee H, Xin Y, Chen Y, Tian W, Cho W (2014) Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling. Nat Commun 5(1):4393","journal-title":"Nat Commun"},{"issue":"30","key":"3783_CR54","doi-asserted-by":"crossref","first-page":"48562","DOI":"10.18632\/oncotarget.10432","volume":"7","author":"J Lee","year":"2016","unstructured":"Lee J, Kee HJ, Min S, Park KC, Park S, Hwang TH, Cheong JH (2016) Integrated omics-analysis reveals Wnt-mediated NAD+ metabolic reprogramming in cancer stem-like cells. Oncotarget 7(30):48562","journal-title":"Oncotarget"},{"issue":"1","key":"3783_CR55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12964-020-0513-5","volume":"18","author":"C Ye","year":"2020","unstructured":"Ye C, Qi L, Li X, Wang J, Yu J, Zhou B, Zheng S (2020) Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt\/\u03b2-catenin signaling via increasing Axin level. Cell Commun Signal 18(1):16","journal-title":"Cell Commun Signal"},{"issue":"3","key":"3783_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/ijo.2023.5483\/abstract","volume":"62","author":"P Liu","year":"2023","unstructured":"Liu P, Liu J, Ding M, Liu Y, Zhang Y, Chen X, Zhou Z (2023) FUT2 promotes the tumorigenicity and metastasis of colorectal cancer cells via the Wnt\/\u03b2-catenin pathway. Int J Oncol 62(3):35. https:\/\/doi.org\/10.3892\/ijo.2023.5483\/abstract","journal-title":"Int J Oncol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03783-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03783-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03783-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:05:37Z","timestamp":1766167537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03783-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3783"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03783-0","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data used in this study was supplied and processed absent of personally identifying information. Written informed consent to participate in the study was obtained from all participants. The study was approved by the ethical research committee of the University of Gothenburg (DNr: 2023\u201303742-02).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This manuscript includes content and materials that were partially created or refined using generative artificial intelligence (AI) tools, including OpenAI's ChatGPT and GitHub Copilot. These tools were utilized for purposes such as language editing and code generation. All AI-generated content was carefully reviewed, edited, and validated by the authors to ensure accuracy and adherence to the objectives and standards of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI disclosure statement"}}],"article-number":"404"}}